p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.
about
Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalBrk/Protein tyrosine kinase 6 phosphorylates p27KIP1, regulating the activity of cyclin D-cyclin-dependent kinase 4The N-terminal region of p27 inhibits HIF-1α protein translation in ribosomal protein S6-dependent manner by regulating PHLPP-Ras-ERK-p90RSK axisSustained proliferation in cancer: Mechanisms and novel therapeutic targetsActivation of the insulin-like growth factor-1 receptor alters p27 regulation by the epidermal growth factor receptor in oral squamous carcinoma cellsEndothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis.Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1)OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma.p27 protein protects metabolically stressed cardiomyocytes from apoptosis by promoting autophagy.Loss of p27 upregulates MnSOD in a STAT3-dependent manner, disrupts intracellular redox activity and enhances cell migration.Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cellsPhosphorylation and subcellular localization of p27Kip1 regulated by hydrogen peroxide modulation in cancer cellsEstrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer.Increased cytoplasmic localization of p27(kip1) and its modulation of RhoA activity during progression of chronic myeloid leukemia.SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers.Stage-specific prognostic biomarkers in melanomaPromotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer.Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.MENX and MEN4Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma.Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.p27Kip1 Is Required to Mediate a G1 Cell Cycle Arrest Downstream of ATM following Genotoxic StressThe histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathwaysEphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasionThe deubiquitylase USP37 links REST to the control of p27 stability and cell proliferationAn essential role of p27 downregulation in fenvalerate-induced cell growth in human uterine leiomyoma and smooth muscle cells.Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.A summary of relationships between alternative splicing and breast cancer.p27(Kip1) V109G polymorphism and cancer risk: a systematic review and meta-analysis.Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors.Signaling pathways that control cell proliferation.PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy.TRIP6 regulates p27 KIP1 to promote tumorigenesis.The non-canonical functions of p27(Kip1) in normal and tumor biology.TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.Differential regulation of cyclin-dependent kinase inhibitors in neuroblastoma cells
P2860
Q26853543-FDAEBC8B-C4FF-495E-9066-27EA9CBCC2CCQ28115769-568C1A0D-490F-469D-ACCF-2AE945A02737Q28383901-E6DEF9AC-7A27-4EF4-B1BF-B91BBEA6F6DAQ28396388-13A672B3-1223-4012-B534-CE0D40391B2FQ30414074-5BEE9FB3-E8A7-474F-A8DF-9FA799807320Q33594656-388A8553-F30B-4313-BAFF-58AC017B6ECAQ33695009-B005A85A-F40E-438E-A202-B12E0ED7FA89Q33728210-9D9E0C00-A2C1-4F87-AD50-10C6D5254B4EQ33761239-3CF53C13-C780-4D1C-BD2E-388471531D7FQ33822389-4F03063C-C6EE-4FF1-B03C-50A26EE64454Q33868788-CAAB1411-CCC6-4CD1-AA9F-8536A243AF08Q34412491-D61BEF8F-52D8-4CE3-A8DA-DE77DA365041Q34430770-99FF780A-39C9-47F3-941F-39D7932976A8Q34969012-0DD105DC-4941-4845-B99F-74F2381A02C5Q35009496-B2939E63-7172-42FC-A4E6-BBB53014097AQ35033669-0A088A67-F5BD-4DDB-822C-80BBEAB01221Q35145084-2EE0105E-531E-4B17-8F8D-08AF75172E7FQ35161905-DC0E5019-EEEA-4AF4-88E8-C8167CDC6DE6Q35551970-C6B2995E-B6FB-45A8-93A0-967B14F8F5A1Q35556101-623DEAEB-9E46-45B1-8A44-0094B4E06841Q35879571-E220D27F-7DF6-4B9F-8F3E-93D32C744516Q35895475-DB9BC3C6-52E5-424E-A80D-0AB147BF742AQ35919052-5856A23D-6A0D-4E77-8AC4-03D1DBD801C0Q35958293-3A3AB87C-70CC-4740-B167-493D121FCDAAQ36128510-8179E5C4-8E82-4DA3-9535-BF2BEFC9EB39Q36157305-6D887F73-6C63-4794-887B-CE98FEBF954AQ36179161-B2E9AADC-F2FB-4D97-8506-59352E9FB356Q36213657-978F54D7-92A4-49E9-AB66-61FC5B24C0CDQ36312422-345B66A1-6B39-413E-B3F3-F0AFC240EA23Q36356155-8513EC09-B55C-44E0-9D3D-58210B59678AQ36378283-D1DC62CC-CD6D-4BAF-B330-69B8DBC5FBE5Q36451110-1C4B15ED-BD1D-49A0-A4A1-EF3763220927Q36489958-0FC776BE-ACFE-4347-9071-EAFAA94BD2BCQ36626696-0062B1A0-18DE-41B1-92ED-31EB46A63B51Q36718464-415B75F7-8011-4D3E-9505-9CBE084AFDAAQ36759860-9BAAD4FD-AA1B-4FBB-AF8D-3083CDF8C5EAQ36956895-4150239A-EA89-442E-AE94-0C49E3C555ADQ36956981-654E24B9-83A7-4F38-8858-91F1D4D56D61Q36985137-5E565F01-6337-466A-B2C5-CED05F34A87DQ37124473-4B8C03F4-7E72-4223-BE59-3F916E3CB0B2
P2860
p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
p27: a barometer of signaling ...... esponse to targeted therapies.
@ast
p27: a barometer of signaling ...... esponse to targeted therapies.
@en
p27: a barometer of signaling ...... esponse to targeted therapies.
@nl
type
label
p27: a barometer of signaling ...... esponse to targeted therapies.
@ast
p27: a barometer of signaling ...... esponse to targeted therapies.
@en
p27: a barometer of signaling ...... esponse to targeted therapies.
@nl
prefLabel
p27: a barometer of signaling ...... esponse to targeted therapies.
@ast
p27: a barometer of signaling ...... esponse to targeted therapies.
@en
p27: a barometer of signaling ...... esponse to targeted therapies.
@nl
P2860
P1476
p27: a barometer of signaling ...... response to targeted therapies
@en
P2093
Joyce M Slingerland
Seth A Wander
P2860
P356
10.1158/1078-0432.CCR-10-0752
P407
P50
P577
2010-10-21T00:00:00Z